Dynavax Technologies Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.19 | Buy/Sell | $130.51 | 9.00% | 11 | $332.28B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
| GSK | GSK | Outperform |
12
|
£17.75 | Buy/Sell | £17.30 | 12.39% | 12 | £72.39B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$67.72 | Buy/Sell | $87.82 | 18.13% | 14 | $84.36B |
| MRNA | Moderna | Outperform |
16
|
$132.90 | Buy/Sell | $135.42 | -5.19% | 1 | $50.93B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 8.96% | 0 | ¥6.48T |
| BNTX | BioNTech | Outperform |
12
|
$90.61 | Buy/Sell | $123.75 | 3.24% | 3 | $21.87B |
| NVAX | Novavax | Outperform |
11
|
$13.01 | Buy/Sell | $23.25 | 19.14% | 4 | $623.13M |
| VBIV | VBI Vaccines | Outperform |
10
|
$0.63 | Buy/Sell | $6.00 | 693.65% | 0 | $18.27M |